Mutations in rpoB That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility
mBio · 2023
DOI: 10.1128/mbio.03168-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2023. Verfasst von Yesha Patel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Cornell University, Ithaca, New York, USA. Hauptthemen laut MEDLINE: Rifampin, Mycobacterium tuberculosis. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, HHS | National Institutes of Health.
Abstract (Originalsprache)
Rifampicin (RIF) is one of the most valued drugs in the treatment of tuberculosis. TB treatment relies on a combination therapy and for multidrug-resistant strains may include β-lactams.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Cornell University, Ithaca, New York, USA.
- Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA.
ORCID-Profile: Yesha Patel, Vijay Soni, Kyu Y Rhee, John D Helmann
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- HHS | National Institutes of Health
Zitieren
APA
Patel, Y., Soni, V., Rhee, K. Y., & Helmann, J. D. (2023). Mutations in rpoB That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility. mBio. https://doi.org/10.1128/mbio.03168-22
Vancouver
Patel Y, Soni V, Rhee KY, Helmann JD. Mutations in rpoB That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility. mBio. 2023. doi:10.1128/mbio.03168-22
BibTeX
@article{Patel2023,
author = {Patel, Yesha and Soni, Vijay and Rhee, Kyu Y and Helmann, John D},
title = {Mutations in rpoB That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility},
journal = {mBio},
year = {2023},
doi = {10.1128/mbio.03168-22}
}
EUVIMED